A new antibiotic to fight the deadly "superbug" C. diff has proved effective in clinical trials. Treating patients with ibezapolstat provided high rates of "sustained" clinical cures, say American ...

As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new ...

SEATTLE – Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, and kills up to 30,000. It is a leading cause of ...

Syracuse, NY — Upstate Medical University is looking for 1,000 volunteers — its largest clinical trial to date — to test a vaccine against a deadly infection that primarily afflicts people in ...